Asco Rally Fizzles: The Nascent Rally In Biotech Stocks Fades

Rod Raynovich • by Roadmap2Retire

CEO of Raygent Associates • May 18, 2019 at 10:59 PM EDT

ASCO Rally Fizzles Two Weeks ahead of May 31-June 4 Meeting: XBI down 0.9% to $83.

ASCO Rally Fizzles Two Weeks ahead of May 31-June 4 Meeting: XBI down 0.9% to $83.

NASDAQ Fades down 0.9%.

RISK still OFF.

Here is a brief snapshot of trading today 30 min before close. Without a NASDAQ rally it is unlikely to have biotech’s moving up.

Gene Therapy Stocks:red screen except BOLD, MGTX and SRPT.
Mid Caps: Mixed but RED with following stocks up:AGIO NKTR SGEN XNCR
Large Caps:Flattish with GILD and RHHBY up.IBB down 0.6% to $103.85.

Disclosure:

Long AAPL, T. My full list of holdings is

available here

Disclaimer: This and other personal blog posts are not reviewed, monitored or endorsed by TalkMarkets. The content is solely the view of the author and TalkMarkets is not responsible for the content of this post in any way. Our curated content which is handpicked by our editorial team may be viewed here.

Comments

Back to TalkMarkets

More from this Author

Healthcare Sector Update After A Tough Week, Looking For Gains Ahead In Biotech

Healthcare Stocks Hit A Speed Bump, But Most TECH Stocks Roll On

Choppy Markets Ahead As We Wait For Q3 Earnings And A Grim September